25,000 Shares in CeriBell (NASDAQ:CBLL) Acquired by Soros Fund Management LLC

Soros Fund Management LLC acquired a new position in shares of CeriBell (NASDAQ:CBLL - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 25,000 shares of the company's stock, valued at approximately $647,000. Soros Fund Management LLC owned 0.07% of CeriBell as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. FMR LLC acquired a new stake in shares of CeriBell in the 4th quarter valued at approximately $128,120,000. Vanguard Group Inc. acquired a new position in CeriBell in the 4th quarter valued at $18,015,000. Board of Trustees of The Leland Stanford Junior University acquired a new stake in shares of CeriBell during the fourth quarter worth $16,143,000. Franklin Resources Inc. acquired a new position in shares of CeriBell during the 4th quarter worth approximately $12,460,000. Finally, Massachusetts Financial Services Co. MA acquired a new position in CeriBell in the 4th quarter valued at $10,750,000.

Analyst Ratings Changes

CBLL has been the subject of several research analyst reports. LADENBURG THALM/SH SH started coverage on shares of CeriBell in a research report on Friday, April 4th. They set a "buy" rating and a $32.00 price objective for the company. Canaccord Genuity Group reissued a "buy" rating and issued a $33.00 price objective on shares of CeriBell in a research note on Wednesday, February 26th. Seven research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $32.50.

Insider Transactions at CeriBell

In other CeriBell news, CEO Xingjuan Chao sold 3,372 shares of CeriBell stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $15.03, for a total transaction of $50,681.16. Following the transaction, the chief executive officer now owns 743,079 shares of the company's stock, valued at $11,168,477.37. This trade represents a 0.45 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 24,700 shares of company stock valued at $372,434 over the last ninety days.

CeriBell Stock Down 2.6 %

Shares of NASDAQ:CBLL traded down $0.43 during mid-day trading on Monday, hitting $15.89. The company had a trading volume of 92,468 shares, compared to its average volume of 269,558. CeriBell has a one year low of $10.01 and a one year high of $32.75. The company has a fifty day moving average of $18.85.

CeriBell (NASDAQ:CBLL - Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The company reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.32) by ($0.08). The firm had revenue of $18.53 million during the quarter, compared to analysts' expectations of $17.55 million. On average, analysts anticipate that CeriBell will post -2.46 EPS for the current fiscal year.

About CeriBell

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.